In Investment Trust

Location: UK

Description

Kromek Group PLC is a United Kingdom-based company which provides digital colour x-ray imaging, enabling direct materials identification in the security, medical, industrial inspection and defense markets. The Company’s portfolio of products includes Nuclear Detection, Security Screening and Medical Imaging. It’s Nuclear Detection which includes, GR1 Spectrometer, Advanced GR1, RadGrid, RadAngel, Spectrometry Software, RayMon10, Quant for RayMon10, RadViz, Food Inspector, RadPro50, RadBot and K102 Multichannel Analyser. It’s Security Screening which includes, Liquid threat Detection, Identifier (Bottle Scanner) Verifier (Bottle Scanner), 2D Imaging Equipments and, 3D Imaging Equipments. Its Medical Imaging which includes, MARS CT, Bone Mineral Densitometry, CZT based Reusable Medical Probes and SPECT.

Visit the company website

Kromek Group PLC

Financial information

We are unable to get the stock information at this time. Sorry for any inconvenience

News about Kromek Group PLC

Kromek Group (LON:KMK) adds UK£10m to market cap in the past 7 days, though investors from five years ago are still down 73%

Kromek Group plc ( LON:KMK ) shareholders will doubtless be very grateful to see the share price up 35% in the last...

Tue, 01 Aug 2023 06:18:01 +0000Read more

Kromek Group rounds off "landmark year"

Kromek Group PLC (AIM:KMK) CEO Arnab Basu speaks to Thomas Warner from Proactive after releasing final results for the year ended 30 April 2023, a period he describes as "in many ways a landmark ye...

Tue, 25 Jul 2023 11:06:04 +0000Read more

Little Excitement Around Kromek Group plc's (LON:KMK) Revenues As Shares Take 29% Pounding

Unfortunately for some shareholders, the Kromek Group plc ( LON:KMK ) share price has dived 29% in the last thirty...

Sat, 27 May 2023 09:27:50 +0000Read more

Kromek Group announces two "key contract" wins

Kromek Group PLC (AIM:KMK) CEO Arnab Basu speaks to Thomas Warner from Proactive following a week of announcements that include two "key contract" wins and a Q3 trading update.

Mon, 24 Apr 2023 07:00:00 +0000Read more

Kromek Group First Half 2023 Earnings: UK£0.012 loss per share (vs UK£0.005 loss in 1H 2022)

Kromek Group ( LON:KMK ) First Half 2023 Results Key Financial Results Revenue: UK£6.79m (up 44% from 1H 2022). Net...

Thu, 02 Feb 2023 05:13:15 +0000Read more

Read more on Yahoo! News

Welcome to the website for Herald Investment Management Limited (HIML). These pages provide a brief introduction to HIML and details of the funds it manages, currently Herald Investment Trust Plc, the Herald Worldwide Technology Fund and two venture capital limited partnerships.

These pages are regularly updated to include up-to-date financial and performance data, but please feel free to contact us with comments, or to request further information. It is important that you read the notices below before proceeding, as they explain certain legal and regulatory restrictions which apply to the information contained in this website.

The information provided in this website is solely for use by individuals who are resident in the United Kingdom and who are subject to UK tax; it is not intended as, and should not be regarded as, an offer or solicitation to sell investments in any jurisdiction other than the UK. Individuals who are not resident in the UK should not continue as it may be contrary to local laws or regulations for them to receive information in connection with, or to apply for, a UK investment. In particular, Herald Investment Trust Plc shares are not registered under United States securities law and, subject to limited exceptions, may not be offered, sold, transferred or delivered in the United States or to US persons. By proceeding, you are representing and warranting that you are not resident in, or a citizen of, a jurisdiction outside the UK.

Stock market and currency movements may cause the capital value of shares and the income derived from them to go down as well as up, and investors may get back less than they invested. Past performance is not necessarily a guide to future performance. The value of any tax relief you may be entitled to will depend on your individual circumstances. Current tax rates and reliefs may be changed by future legislation.

This website has been approved for purposes of UK regulation by Herald Investment Management Ltd which is authorised and regulated by the Financial Conduct Authority.

Although we have taken reasonable care to ensure that the facts contained in these pages are accurate, no representation or warranty, express or implied, is made as to their accuracy or completeness. The contents of the website are not to be considered as investment advice.

The information on this website is not for distribution outside the UK. Under no circumstances should this information, or any part of it be copied, reproduced or redistributed. No rights of any kind are licensed or assigned or shall otherwise pass to persons accessing this information.

If you are in any doubt about any of the information contained on this website please consult your stockbroker, solicitor, accountant or other professional adviser.